ESICM 2021 Research Awards

Those pre-selected for the Basic Research Awards have the opportunity to compete for the Professor Burkhard Lachmann Award for Experimental Research. The jury considered the projects competing in the 2020 Basic Awards category. The award  allocates a grant amounting to € 5,000 which is  funded by the International Foundation for Clinically Oriented Research (IFCOR). 

2021 Awardee: Marta Camprubí Rimblas “Response of Human Alveolar Epithelial Cells cultured with different types of bacteria at hypercapnic conditions (AEBCO2)”

The project should cover families’ needs and expectations, care providers & patient interactions, long-term outcomes in ICU survivors. The plan should be conducted within a 12-month work period in a European country. We encourage N&AHP members to apply.

The Family Partnership Award allocates a grant amounting to 15,000€, which is fully funded by ESICM. 

2021 Awardee: Matteo Danielis “Family ENgagement in Intensive Care Environments (FENICE): A quasi-experimental study”

The Global ICU Award aims at projects conducted in a Low & Middle Income Country. The projects should have an educational element focusing on improving patient care. Eligible Low & Middle Income Countries are based on the 2020 low and middle income countries list compiled by the World Bank and approved by the WHO.

The Global ICU Award allocates a grant amounting to 15,000€, which is fully funded by ESICM. 

2021 Awardee: Ping Guo “Capacity building in research and end-of-life care for ICU clinicians in Uganda: An innovative ‘learning by doing’ model”.

The Established Investigator Award supports the research activities of a senior physician/scientist active in clinical or basic research. It supports a research project conducted in Europe. The specific intent is to provide support for investigators who have already established their independent research programme in the field of intensive care and emergency medicine, and who can demonstrate a commitment to facilitate research training of young colleagues. The research proposal may rely on approaches ranging from basic cellular responses to outcome research, and may include clinical applications as well as translational science.

The Established Investigator Award allocates a grant amounting to 20,000€, which is also fully funded by ESICM.

2021 Awardee: Sam Hutchings “Assessment of the clinical utility of point of care ultrasound in assessing venous congestion in critically ill patients“

The ESICM Young Investigator Award supports the development of research activities undertaken with the active contribution of the applicant. It supports a research project conducted in Europe by an investigator under the age of 40 at the time of the application. The specific intent is to provide support for young and talented physicians/scientists that have the potential to become outstanding independent investigators in the field of intensive care. Research proposals may rely on approaches ranging from basic cellular responses to outcome research, and may include clinical applications as well as translational science.

The Young Investigator Award allocates a grant amounting to 20,000€, which is fully funded by ESICM. Only ESICM members aged 40 years or younger are invited to submit applications.

2021 Awardee: Johannes Herrmann: “Impact of Platelet Mitochondrial Function on Thromboinflammation during Acute Respiratory distress Syndrome (ARDS)”

The NEXT Start-Up Grant supports the professional development of talented newly board-certified intensivists who already have a background in research and are willing to develop independent research programmes. The specific intent is to provide support for young and talented researchers/scientists who have the potential to become established independent investigators in the field of intensive care. Board-certified Intensive Care Physicians within 5-years from consultancy, who can demonstrate a solid background in research (e.g. PhD, MD, publications list/reference), are invited to apply. Applicants must demonstrate institutional support to facilitate research activities and professional development. Only ESICM members aged 42 years or younger are invited to submit applications

Research programme proposals may rely on approaches ranging from basic cellular responses to outcome research, and may include clinical applications, as well as translational science. Timetable and milestones definition are required. Research programme timetable specification, including milestones and objectives are also required at time of application.  A progress report should be submitted by the researcher to the Society after one year. Dissemination of results through ESICM events and journals, within three years following grant allocation, is required. There will also be long-term follow-up of professional development as an established independent researcher.

The NEXT Start-Up Grant allocates a grant amounting to 25,000€ per year for up to two years. This grant is fully funded by ESICM.

2021 Awardee: Vincenzo Russotto: “Preventing cardiovasculaR collapsE with VasoprEssors duriNg Tracheal IntubatiON: The PREVENTION Randomized Controlled Trial”.

The Clinical Research Award supports a research project to be performed by an investigator in a clinical environment. Some aspects of the proposal may involve collaboration with research laboratories. However, applications that lack a clinical component will not be considered. Proposals may be based on approaches ranging from physiology, diagnostic procedures, therapeutic interventions, to epidemiologic studies and evaluation of practices.
The Clinical Research Award allocates two grants amounting to 20,000€ each, which are fully funded by ESICM.

2021 Awardees:

Elisa Gouvêa Bogossian: “Ketone Therapy to Reduce Energy Dysfunction after Severe Traumatic Brain Injury”

Matthijs Kox: “Clinical phenotypes in COVID-19 patients and their relationship with outcome”.

The Basic Science Award supports a research project to be performed by an investigator in a research laboratory. Approaches may vary topically from basic cellular and molecular physiology, cell biology, molecular biology and genetics to animal physiology and translational science.

The Basic Science Award allocates two grants amounting to 20,000€ each, which are also fully funded by ESICM.

2021 Awardees:

Frédéric Pène: “Respiratory Epithelium in Post-Septic Immunosuppression”

Charissa van den Brom: “Sex differences and the effectiveness of targeting the endothelium following traumatic hemorrhagic shock”.

In order to foster progression of women in academic careers, this prize supports the development of research activities undertaken with the active contribution of a female applicant. The specific intent is to provide support for young and talented female physicians/scientists who have the potential to become outstanding independent investigators in the field of intensive care and emergency medicine. The research proposal may focus on approaches to topics ranging from basic cellular responses to outcome research, and may include clinical applications as well as translational science.

The Levi-Montalcini Biomedical Sciences Award allocates a grant amounting to 20,000€, which is also fully funded by ESICM.

2021 Awardee: Julia Leonhardt “Bile Acid Profiles in Liver Failure – Impact on Immunity, Infections and Mortality (BILE)” 

This award is available for the first time in 2021. Projects must focus on the Physiology-based Management of Respiratory Failure. The amount allocated by Fisher&Paykel Healthcare is € 20,000. Projects must be conducted in Europe. The proposals should include at least one country contributing to the design/and/or conduct of the project.

2021 Awardee: Nuttha Lumlertgul: “Ventilation induced kidney injury (VIKI) ”